Content uploaded by Dnyaneswar Kale
Author content
All content in this area was uploaded by Dnyaneswar Kale on Feb 19, 2024
Content may be subject to copyright.
49
International Journal of Toxicology and Applied Pharmacology 2012; 2(4): 49-51
ISSN 2249–9709
Original Article
In vitro antibacterial activity of Emblica officinalis fruit extract by
tube Dilution Method
Satyajit G. Patil, Deshmukh A. A., Amol R. Padol1, Dnyaneshwar B. Kale2
Department of Veterinary Pharmacology and Toxicology, College of Veterinary and Animal Sciences, Udgir, Maharashtra
1Department of Veterinary Pharmacology and Toxicology, Veterinary College, KVAFSU, Hebbal, Bangalore, Karnataka
2Department of Veterinary Pathology, Post Graduate Institute of Veterinary and Animal Sciences,
Akola, Maharashtra (India)
E-mail: patil.satyajit@rediffmail.com
Received 20 October 2012; accepted 09 November 2012
Abstract
The study was carried out to assess in vitro antibacterial activity of aqueous and organic namely acetone, chloroform, ethyl
acetate and methanol extracts of Emblica officinalis fruits against four commonly encountered pathogenic strains of
Escherichia coli, Staphylococcus aureus, Klebsiella pneumoniae and Pasteurella multocida by tube dilution method. The
present study revealed that there was significant reduction in the mean colony count of E.coli (293 ± 1.86 to 108.33 ± 0.67)
and P. multocida (301.67 ± 2.03 to 139.67 ± 2.40) by the acetone extract, whereas there was significant reduction in the
mean colony count of S. aureus (134.33 ± 2.40 to 256.33 ± 2.33) by the methanol extract and significant reduction in the
mean colony count of K. pneumoniae (201.00 ± 2.31 to 267.33 ± 3.28) by the aqueous extract. The aqueous, acetone, ethyl
acetate and methanol extract were found to be effective against all the microorganisms under test where as chloroform
extract was effective against E.coli and P.multocida but S. aureus and K. pneumoniae were found to be resistant against
chloroform extract of E. officinalis. The outcome of the present investigation concludes that the E. officinalis fruit contain
the antibacterial active ingredients. © 2012 Universal Research Publications. All rights reserved
Key Words: Emblica officinalis, antibacterial activity, tube dilution, bacterial resistance.
1. Introduction
The plant Emblica officinalis (Synonym- Phyllanthus
emblica linn.) known as Indian gooseberry and Amla in
India. The medicinal properties of E. officinalis can be
traced back in the ancient medical treatise like
Ayurveda, Ramayana, Charak Samhita, Sushrut Samhita
and other archaic literatures. The plant belongs to family
Euphorbiaceae and is one of the most celebrated herbs in
the Indian traditional medicinal system widely distributed
throughout India. Almost all parts of the plant are of great
medicinal and nutritive values and being used in ayurvedic
preparations for human and animal therapeutics.
The varied literature on the medicinal plant reveals that the
plant E. officinalis have the antibacterial [1, 2, 3] antifungal
[1, 4], antioxidant [5], cardio-protective [6], anthelmintic
[7] and anti-inflammatory properties [8]. The plant E.
officinalis is useful in conjunctivitis, inflammation,
dyspepsia, ulcerative stomatitis, gastrohelicosis, cough,
diarrhoea, dysentery, diabetes, asthma, bronchitis,
opthmopathy, colic, jaundice, emaciation, cardiac disorder,
intermittent fever, hepatopathy, hemorrhages, menorrhagia
and skin diseases [9, 10]. The major active principles of E.
officinalis fruit are flavonoids (quercetin), phyllemblin,
ascorbic acid, gallic acid alkaloids (phyllantine,
phyllantidine) and tannins (emblicanin A and emblicanin
B). Vitamin C, tannins and flavonoids are found in
maximum concentration and are antioxidant in action [11].
Various reports are available confirming the in vitro and in
vivo antibacterial potency of E. officinalis. In an
experimentally induced pneumonia with Klebsiella
pneumoniae in mice, the fruits of E. officinalis was
reported to inhibit the colonization of organism in lungs
[12].
Present day antibacterial therapy for bacterial diseases is
mainly focused by use of antibiotics and numerous
synthetic antibacterial drugs. In spite of national and
international policies for use of antibacterials,
indiscriminate use of antibiotics and antibacterials is of
great concern due to the development of resistant strains of
organisms, toxicity, side effects and accumulation of drug
residues in the body tissue and fluids. Resistance has
emerged even to newer, more potent antimicrobial agents
like carbapenems. This situation demands the need of more
safe and effective therapeutics for treating the infectious
Available online at http://www.urpjournals.com
International Journal of Toxicology and Applied Pharmacology
Universal Research Publications. All rights reserved
50
International Journal of Toxicology and Applied Pharmacology 2012; 2(4): 49-51
diseases. The need for new therapeutics for infectious
diseases has encouraged the drive to examine the nature
and value of E. officinalis fruits. Therefore, an attempt was
made to assess the antibacterial property of E. officinalis
using tube dilution method against some common bacterial
pathogens of both human and farm animals.
2. Material and Methods
2.1. Preparation of extract
The fruit powder of E. officinalis was procured from the
authorized Ayurvedic pharmacy. The fine powder of fruit
of E. officinalis was subjected for preparation of different
extracts namely aqueous, acetone, chloroform, ethyl acetate
and methanol. The extractability percentage was
determined as per the method suggested by Rosenthaler
[13].
2.2. Test organism
The test organisms selected in the present study based on
their pattern of occurrence in the dairy animals and poultry.
S. aureus and E. coli are the common pathogens causing
mastitis, metritis, pyometra and other economically
important infectious diseases in the dairy animals.
Haemorrhagic septicemia caused by P. multocida leads to
heavy economic losses in terms of reduced production and
mortality especially in the buffalos. K. pneumoniae is the
other important pathogen infecting the respiratory and
reproductive system.
Pure cultures of Escherichia coli (MTCC,
No.723) Staphylococcus aureus, (MTCC No.96),
Klebsiella pneumoniae (MTCC No.106) and Pasteurella
multocida (MTCC No.1161) were obtained from Institute
of Microbial Technology, Chandigarh, India. The
pathogenic bacterial culture was sub cultured and
maintained on nutrient agar and in nutrient broth.
2.3. Preparation of extract impregnated disc
The sterile blank discs of filter paper were procured from
M/s Hi Media Laboratories Ltd. Mumbai. These blank
discs were separately impregnated with different extracts
until the disc get fully saturated. The discs were weighed
before and after impregnation of the extract. The amount of
the E. officinalis extract actually got impregnated on to the
disc was 19.79 ± 0.37 for methanol, 13.87 ± 0.29 for
acetone, 12.26 ± 0.21 for aqueous, 9.91 ± 0.11 for ethyl
acetate and 6.83 ± 0.47 for chloroform.
2.4. Determination of antibacterial activity
The antibacterial effectiveness of fruit extract of E.
officinalis was determined by tube dilution method [14].
The test tube containing 3 ml of nutrient broth was added
with a loop full of 24 hr old broth culture of each bacterium
under test. The tubes were then incubated for 4 hrs. The
bacterial dilutions were made ranging from10-6 to 10-3. Two
extract impregnated discs were placed in each tube and
incubated at 37 0C for 24 hr. The broth in the tube was then
plated on the nutrient agar taken in petri plates. After 24 hr
of incubation at 37 0 C, the bacterial growth in each petri
plate was assessed by counting the bacterial colonies.
Based on the observations the bacterial dilution of 10-6 was
selected for the final test.
For the final tube dilution test bacterial culture (10-6) taken
in tubes were added with two extract impregnated discs and
incubated at 37 0C. After overnight incubation the cultures
(broth) were poured on nutrient agar taken in petri plates.
The excess of broth was drained off after 3 minutes. After
further incubation of 24 hr, the colonies were counted for
each plate.
The data of this investigation were statistically analyzed by
student t test and the results were represented as mean ±
standard error [15].
3. Results
The mean colony count of E. coli without treatment was
293 ± 1.86. The mean colony count of E. coli with
treatment of chloroform extract of E. officinalis fruit was
212 ± 1.15 followed by treatment of ethyl acetate (163 ±
3.79), aqueous (130.33 ± 0.88), methanol (12.67 ± 1.76)
and acetone (108.33 ± 0.67) fruit extract of E. officinalis.
The mean bacterial colony count of S. aureus without
treatment was 256.33 ± 2.33.The mean bacterial colony
count with methanol fruit extract was 134.33 ± 2.40
followed by acetone (148.33± 1.20), aqueous (160.67 ±
2.60), ethyl acetate (189.33 ± 1.20) and chloroform (227.00
± 1.53) fruit extracts.
The mean colony count of K. pnumoniae without any
treatment was 267.33 ± 3.28.The mean colony count by
treatment of aqueous extract of E. officinalis (201.00 ±
2.31) was the lowest among all the extracts. The mean
bacterial colony count by the treatment with methanol
extract of E. officinalis fruit (210.33 ± 1.45) was
statistically similar to the mean colony count by the
treatment with Acetone fruit extract of E. officinalis
(213.67 ± 3.18). The mean colony count by the treatment
with ethyl acetate was 225.00 ± 2.31. The mean colony
counts without treatment and with the chloroform extract
(260.00 ± 3.18) were statistically similar to each other.
The mean colony count of P. multocida without treatment
was 301.67 ± 2.03.The mean colony count of P. multocida
by the treatment with Methanol fruit extract (142.33 ±
1.45) was statistically similar to the mean colony count of
P. multocida by the treatment with Acetone extract of fruit
of E. officinalis (139.67 ± 2.40). The mean colony count of
P. multocida by the treatment with chloroform was highest
among all the extract followed ethyl acetate, aqueous,
methanol and acetone.
4. Discussion
The antibacterial activity of E. officinalis fruit extract was
evaluated against four pathogenic bacteria belonging to
both Gram positive and Gram negative group.
The acetone fruit extract has maximal activity against E.
coli and P. multocida. The methanol extract has maximal
antibacterial activity against S. aureus where as the
aqueous extract have maximum antibacterial activity
against K. pneumoniae. The results of the present
investigation were in accordance with the reports of Saeed
and Tariq [16], wherein, the E. officinalis have been found
to be active against a range of bacteria including
Staphylococcus aureus, S. haemolyticus, S. saprophyticus,
Micrococccus varians, Bacillus subtilis and also against
Candida albicans.
It was also apparent from the studies by the tube dilution
that out of different extracts of E. officinalis the acetone
fruit extract has the maximal antibacterial activity against
E.coli than by other extract against other test organisms.
51
International Journal of Toxicology and Applied Pharmacology 2012; 2(4): 49-51
The antibacterial activity exhibited by the E. officinalis
could be attributed to the presence of bioactive components
namely flavonoids, phenols, saponins, tannins in the fruit
extract [17]. Among these active principles the saponins are
known to have potent bactericidal potency among the
others. The fruit also contains tannins Emblicanin A and B,
which are known to have potent antimicrobial activities
[18].
Various investigators have reported that the fruits of E.
officinalis have immune-modulatory activity [19, 20, 21].
The properties of immunomodulation and antibacterial
potency of E. officinalis could be utilized synergistically
for the treatment of infectious diseases in the immune-
compromised individuals.
5. Conclusion
In the present investigation, the different solvent extracts of
E. officinalis shown to have antibacterial activity against
commonly encountered pathogens. The use of E. officinalis
in the treatment of could be the safe, potent and cost
effective way to treat infectious diseases of livestock,
poultry and human.
6. References
1. M.M. Hossain, K. Mazumder, S. M. M. Hossen, T.T.
Tanmy, Md. J. Rashid, in vitro studies on antibacterial
and antifungal activities of emblica officinalis Int. J.
Pharma. Sci. Res. 3(2012) 1124-1127.
2. J. Philip, Sheila John and Priya Iyer, Antimicrobial
Activity of Aloevera barbedensis, Daucus carota,
Emblica officinalis, Honey and Punica granatum and
formulation of a health drink and salad, Malays. J.
Microbiol, 8 (2012) 141-147.
3. N.P. Usha, K.J. Bibu, S. Jose, A.M.C Nair, G.K. Nair,
N.D. Nair, Antibacterial activity of successive extracts
of some medicinal plants against field isolates of
Pasteurella multocida, Indian J. Ani. Sci. 82(2012)
1146–1149.
4. Z. Mehmood, I. Ahmed, F. Mohammad, S. Ahmed,
Indian medicinal plant a potential source for
anticandidal drugs, Pharm. Biol. 37(1999) 237-242.
5. M. Golechha, J. Bhatia, D. Arya, Studies on effects of
Emblica officinalis (Amla) on oxidative stress and
cholinergic function in scopolamine induced amnesia
in mice, J. Environ. Biol. 33(2012) 95-100.
6. S.K. Bhattacharya, A. Bhattacharya, K. Sairam, and S.
Ghosal, Effect of bioactive tannoid principles of
Emblica officinalis on ischemia-reperfusion-induced
oxidative stress in rat heart, Phytomedicine, 9(2002)
171 - 174.
7. G. Dwivedi, A.A. Noorani, D. Rawal, H. Patidar,
Anthelmintic activity of Emblica officinalis fruit
extract, Int. J. Pharma. Res. Dev. 3(2011) 50-52.
8. L.C. Mishra, Scientific basis of Ayurvedic therapies,
second ed., CRC press, 2004.
9. C. Parmar, M.K. Kaushal, Wild fruits, first ed.,
Kalyani Publication, New Delhi, 1982.
10. J. Anjaria, M. Parabiam, S. Dwivedi,
Ethnovet Heritage, first ed., Prathik Enterprizes,
Ahemadabad, 2002.
11. S. Kaur, S. Arora, K. Kaura, The in vitro
antimutagenic activity of Triphlaan Indian herbal drug,
Food Chem. Toxicol. 40(2002) 527-534.
12. A. Saini, S. Sharma, S. Chhibber, Protective efficacy
of Emblica officinalis against Klebsiella pneumoniae
induced pneumonia in mice, Indian J. Med. Res.
128(2008) 188-193.
13. L. Rosenthaler, The chemical investigation of plants,
first ed., Bell and Sons, London, 1930.
14. R. Cruickshank, J.P. Duguid, B.P. Marmion, R.H.A.
Swain, Medical Microbiology, twelfth ed., The English
Language Book Society and E and S, Churchill
Livingstone, Edinburgh, 1975.
15. G.W. Snedecor, W.G. Cochran, Statistical Methods,
third ed., Oxford and IBM publication Co., Calcutta,
1967.
16. S. Saeed, P. Tariq, Antimicrobial activities of Emblica
officinalis and Coriandrum sativum against Gram
positive bacteria and Candida albicans, Pak. J. Bot.,
39(2007) 913-917.
17. P. Javale, S. Sabnis, Antimicrobial properties and
phytochemical analysis of Emblica officinalis, Asian J.
Exp. Biol. Sci. (2010) 91-95
18. K.S. Jyothi, B. Subba Rao, screening of antibacterial
activity of Emblica officialis fruits,
Pharmacologyonline, 3(2011) 848-852.
19. R. Rama Rao, Interpretation of AIDS with traditional
immunity therapy, Proceedings of international
seminar on complimentary medicine in AIDS, MAPA
20 (1998) 28-35.
20. M.D. Sairam, B. Neetu, B. Yogis, B. Anju, P. Dipti,
Cyto-protective and immunomodulating properties of
Amla (Emblica officinalis) on lymphocytes: An in
vitro study, J. Ethnopharmacol. 81(2002) 5-10.
21. L.D. Ganju, S. Karan, S. Chanda, K.K. Srivastava,
R.C. Sawhney, W. Selvamurthy, Immunomodulatory
effects of agents of plant origin, Biomed.
Pharmacother. 57(2003) 296-300.
Source of support: Nil; Conflict of interest: None declared